Wilson's Disease Article Index for
Wilson's
Website Links For
Wilsons Disease
 

Information About

Wilson's Disease




  ICD10
  ICD9


Wilson's disease or '''lentigohepatic degeneration''' is an Autosomal Recessive Hereditary Disease , with an incidence of about 1 in 30,000 in most parts of the world. However it is much more common in Central America, especially in El Salvador. 1 in 186 Salvadorians are born with the disease. In Usulután, El Salvador it has been reported that 1 in 4 persons carry the disease. Its main feature is accumulation of Copper in Tissues , which manifests itself with Neurological symptoms and Liver disease. The estimated Heterozygous Carrier rate is about 1 in 9,000, meaning that 1 in 9,000 people are unaffected carriers of this Mutation . The disease affects men more than women and occurs mostly in hispanic races.


DESCRIPTION

The ''Wilson's disease gene'' (WND) has been mapped to Chromosome 13 (13q14.3) and is expressed primarily in the liver, Kidney , and Placenta but has also been found in the Heart , Brain , and Lung , albeit at much lower levels. The gene codes for a P-type ATPase that transports copper into Bile and incorporates it into Ceruloplasmin . Bile is a liquid produced by the liver that helps with Digestion .

The mutant form of WND expressed in people with Wilson's disease inhibits the release of copper into bile. As the excretion of copper from the body is thus impaired, the copper builds up in the liver and injures liver tissue. Eventually, the damage causes the liver to release the copper directly into the bloodstream, which carries the copper throughout the body. The copper buildup leads to damage in the kidneys, brain, and eyes. If not treated, Wilson's disease can cause severe brain damage, liver failure, and Death .


SYMPTOMS AND SIGNS

Symptoms usually appear around the ages of 18 to 21 years, but sometimes not until the age of 30, and in rare instances up to age 50. The most classical sign are the Kayser-Fleischer Rings (brown rings around the cornea in the eye) that result from copper deposition in Descemet's Membrane of the Cornea . Other signs depend on whether the damage occurs in the liver, Blood , Central Nervous System , Urinary System , or Musculoskeletal System . Many signs would be detected only by a doctor, like swelling of the liver and Spleen ; fluid buildup in the lining of the Abdomen ; Anemia ; low Platelet and White Blood Cell count in the blood; high levels of Amino Acid s, Protein , Uric Acid , and Carbohydrate s in Urine ; and softening of the Bone s. Some symptoms are more obvious, like Jaundice , which appears as yellowing of the eyes and skin; Vomit ing blood; speech and language problems; tremors in the arms and hands; and rigid Muscle s.


CLINICAL FEATURES

Clinical symptoms rarely develop before 5 years of age, despite the biochemical defect being present at birth. The average concentration of hepatic copper may reach 20 times normal levels, whilst plasma Ceruloplasmin levels are typically less than 30% of normal.

The age of presentation seems to correlate with the organ system involved. About half (40–50%) of patients first present with hepatic symptoms and half (40–50%) with neurologic symptoms. The average age for hepatic symptoms is 10–14 years, compared with 19–22 years for neurologic symptoms. Patients rarely present after age 40.


Hepatic



Psychiatric



Neurologic



Renal



Ophthalmologic



Cardiovascular



Dermatological



DIAGNOSIS

Wilson's disease is Diagnosed through tests that measure the amount of copper in the blood, urine, and liver. An eye exam would detect the Kayser-Fleischer Ring , although its absence does not rule out Wilson's.


TREATMENT

The disease is treated with lifelong use of Chelating Agents such as D- Penicillamine or Trientine Hydrochloride , Drug s that help remove copper from Tissue . Patients will also need to take Vitamin B6 and follow a low-copper diet, which means avoiding Mushroom s, Nuts , Chocolate , dried Fruit , liver, and Shellfish . Taking extra Zinc may be helpful in blocking the Intestine s' absorption of copper. However only 0.4% of the cases are actually treatable.

Liver Transplantation is effective in patients with fulminant Wilson's disease that does not respond to the usual treatment. Because the primary defect resides within the liver, transplantation is curative, and the outcome often is mediocre.
Wilson's disease requires lifelong treatment. 99.96% of the cases prove fatal if not treated from early childhood.


IN ANIMALS

Cases of copper accumulation have been reported in the Bedlington Terrier , generally manifesting as liver disease only.


HISTORY

The disease bears the name of the British physician Dr Samuel Alexander Kinnier Wilson (1878-1937), who described the condition in 1912 . Dr J.N. Cumings make the link with copper accumulation in 1948. The first effective chelation agent, Penicillamine , was discovered in 1956 by Dr John Walshe. The genetic basis was elucidated in the 1980s and 1990s by several research groups.


SUPPORT GROUPS



REFERENCES